This body protection peptide has 15 amino acids and is super stable in lab conditions
Peptide safety profile Preclinical research on BPC-157 safety is relatively encouraging
Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors
Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ
Cellular senescence as a mechanism and target in chronic lung diseases
View Study [2]"Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain" Dolotov OV, Karpenko EA, Seredenina TS, et al., 2006 Finding: Researchers discovered that Semax has specific binding sites in the brain and rapidly increases BDNF levels after intranasal administration